Several studies have demonstrated that AKT signaling accelerates the progression of CRC cells.14 In addition, ITGB4 and LAMB3 are important upstream activators of AKT, which is why we focused on the AKT signaling pathway. The gene discussed is ITGB4; the disease is colorectal carcinoma.